Pharmacological analyses of learning and memory in zebrafish (Danio rerio)

Pharmacology, Biochemistry, and Behavior
Jordan M BaileyEdward D Levin

Abstract

Over the last decade, zebrafish (Danio rerio) have become valuable as a complementary model in behavioral pharmacology, opening a new avenue for understanding the relationships between drug action and behavior. This species offers a useful intermediate approach bridging the gap between in vitro studies and traditional mammalian models. Zebrafish offer great advantages of economy compared to their rodent counterparts, their complex brains and behavioral repertoire offer great translational potential relative to in vitro models. The development and validation of a variety of tests to measure behavior, including cognition, in zebrafish have set the stage for the use of this animal for behavioral pharmacology studies. This has led to research into the basic mechanisms of cognitive function as well as screening for potential cognition-improving drug therapies, among other lines of research. As with all models, zebrafish have limitations, which span pharmacokinetic challenges to difficulties quantifying behavior. The use, efficacy and limitations associated with a zebrafish model of cognitive function are discussed in this review, within the context of behavioral pharmacology.

References

Mar 1, 1992·Progress in Neuro-psychopharmacology & Biological Psychiatry·D M Warburton
Jan 1, 1966·Psychological Review·R F Thompson, W A Spencer
Sep 13, 2001·Proceedings of the National Academy of Sciences of the United States of America·T Darland, J E Dowling
Sep 14, 2001·Current Drug Targets·C CastellanoA Ciamei
May 29, 2003·Current Drug Targets. CNS and Neurological Disorders·E D Levin, A H Rezvani
Sep 29, 2004·Neurotoxicology and Teratology·Edward D Levin, Elaine Chen
Jun 22, 2005·Behavioural Processes·Ruth M ColwillHolly Escudero
Sep 22, 2005·Psychopharmacology·Edward D LevinMiram Peterson
Jul 1, 2006·Methods : a Companion to Methods in Enzymology·Jovica Ninkovic, Laure Bally-Cuif
Aug 22, 2008·Psychopharmacology·Donnie EddinsEdward D Levin
Oct 16, 2008·Neurobiology of Learning and Memory·Catharine H RankinRichard F Thompson
Feb 3, 2009·Alcoholism, Clinical and Experimental Research·Yohaan Fernandes, Robert Gerlai
Feb 17, 2009·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·L P V Cofiel, R Mattioli
Jul 14, 2009·Neurobiology of Learning and Memory·Martina BlankMonica R M Vianna
Jan 2, 2010·Behavioural Brain Research·Luis M Gómez-Laplaza, Robert Gerlai
Feb 5, 2010·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Kara D MannPatrick S Page-McCaw
Mar 20, 2010·Neuroscience Research·Yeon-Hwa KimChang-Joong Lee
May 25, 2010·Alcoholism, Clinical and Experimental Research·Catharine A WinstanleyJ David Jentsch
Jun 22, 2010·Behavioural Brain Research·Leah GrossmanAllan V Kalueff
Aug 4, 2010·BMC Neuroscience·William Norton, Laure Bally-Cuif
Oct 5, 2010·Behavioural Brain Research·S K RichettiC D Bonan
Nov 3, 2010·Neurotoxicology and Teratology·Christina M PowersTheodore A Slotkin
Mar 5, 2011·Brain Research Bulletin·Leah GrossmanAllan V Kalueff
Mar 5, 2011·Nature Protocols·Priya MathurSu Guo
May 14, 2011·Developmental Neurobiology·Filippo Del Bene, Claire Wyart
May 21, 2011·Neurobiology of Learning and Memory·Margarette Sison, Robert Gerlai
Jun 15, 2011·Behavioural Brain Research·Kelly Juliana SeibtCarla Denise Bonan
Jun 15, 2011·Birth Defects Research. Part C, Embryo Today : Reviews·Shaukat AliMichael K Richardson
Jul 12, 2011·Neurotoxicology and Teratology·Edward D LevinElwood Linney
Sep 13, 2011·Neurotoxicology and Teratology·E P RicoC D Bonan
Oct 11, 2011·Journal of Comparative Physiology. A, Neuroethology, Sensory, Neural, and Behavioral Physiology·Yen-Chyi LiuMelina E Hale
Nov 9, 2011·Behavioural Brain Research·Matthew O ParkerCaroline H Brennan
Feb 14, 2012·Developmental Neurobiology·Suresh Jesuthasan
Nov 28, 2012·Birth Defects Research. Part A, Clinical and Molecular Teratology·Chengjin ZhangGregory J Cole
Jun 1, 2013·Birth Defects Research. Part C, Embryo Today : Reviews·Jordan BaileyEdward D Levin
Jun 26, 2013·Behavioural Processes·D T CeruttiJ E R Staddon
Jul 3, 2013·Behavioural Pharmacology·Adam D Collier, David J Echevarria

❮ Previous
Next ❯

Citations

Jan 17, 2016·Progress in Neuro-psychopharmacology & Biological Psychiatry·Mohammad NaderiDouglas P Chivers
May 27, 2017·Development, Growth & Differentiation·Hideaki Matsui
Mar 18, 2020·Zebrafish·Greta BarattiValeria Anna Sovrano
May 29, 2020·SLAS Discovery·Davide RubbiniVincenzo Di Donato
Dec 31, 2019·Evidence-based Complementary and Alternative Medicine : ECAM·Elena Todirascu-CiorneaAbdel Nasser B Singab
Sep 6, 2020·Progress in Neuro-psychopharmacology & Biological Psychiatry·Barbara D FontanaMatthew O Parker
May 4, 2021·Brain and Behavior·Jaquelinne Pinheiro-da-Silva, Ana Carolina Luchiari
Jul 2, 2021·Pharmacology, Biochemistry, and Behavior·Andrew B HawkeyKyoko Koshibu
Nov 6, 2021·Genesis : the Journal of Genetics and Development·Yohaan Fernandes, C Ben Lovely

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine
You-hua WangSimon Ming-yuen Lee
Future Medicinal Chemistry
Bhaskar C DasTodd Evans
Trends in Pharmacological Sciences
Allan V KalueffRobert Gerlai
Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP
Evan T Keller, Jill M Murtha
© 2021 Meta ULC. All rights reserved